FDA Inspection 970700 — Oklahoma Blood Institute East Central
The FDA completed an inspection of Oklahoma Blood Institute East Central on Mar 16, 2016 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 16, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ada, OK (United States)